ENOXABARA® Enoxaparin 40 mg | Libya (BAYADERCARE)

Advanced solution designed to reduce the risk of thrombosis and improve patient safety.

Enoxaparin 40 mg Injection | BAYADERCARE Libya

Preventive anticoagulation is a key component in modern clinical care, particularly in reducing the risk of thromboembolic complications in surgical and immobilized patients. Low molecular weight heparins (LMWH) are widely used across Libyan healthcare settings due to their predictable pharmacokinetics, safety profile, and ease of administration.

ENOXABARA® (Enoxaparin Injection) is developed by RAWIA INTERNATIONAL HEALTHCARE (RIHCA) in collaboration with leading pharmaceutical manufacturing partners and is available across Libya through BAYADERCARE. The 40 mg strength is specifically designed for thromboprophylaxis, supporting hospitals, clinics, and healthcare providers in Tripoli, Benghazi, Misrata, and across Libya — To Share • To Care • To Inspire.
ENOXABARA® 40 mg (Enoxaparin Sodium Injection) is a low molecular weight heparin (LMWH) used for the prevention of thromboembolic disorders. It works by inhibiting factor Xa activity, reducing clot formation and maintaining stable blood flow.
This strength is commonly used in post-surgical care, immobilized patients, and hospital-based thromboprophylaxis protocols under medical supervision.
Specifications Table:
Parameter Details
Brand Name ENOXABARA®
Generic Name Enoxaparin Sodium
Arabic Name إينوكسابارا إينوكسابارين
Category Anticoagulants
Therapeutic Area Low Molecular Weight Heparin (LMWH)
Dosage Form Injection
Strength 40 mg
Volume 0.4 ml
Route / Type Subcutaneous (Anti-Xa)
Developed By RIHCA
Marketed By RAWIACARE
Availability Libya via BAYADERCARE
Official Libya Proxy BAYADERCARE
Official Global Platform RAWIACARE / RAWIACARE GLOBAL
Corporate Philosophy TO SHARE • TO CARE • TO INSPIRE
Applications / Uses:
Prevention of Deep Vein Thrombosis (DVT)
Post-surgical thromboprophylaxis
Prevention of Venous Thromboembolism (VTE)
Anticoagulant support in immobilized patients
Hospital-based preventive protocols

FAQ

Is ENOXABARA 40 mg available in Libya?

Yes, it is available through BAYADERCARE across Libya.

Prevention of thromboembolic conditions such as DVT.

 

Hospitals, surgical units, and clinics.

 

Enoxaparin 60 mg injection Libya BAYADERCARE anticoagulant therapy

Enoxabara Enoxaparin 60 mg Injection

Enoxabara Enoxaparin 60 mg Anti-Xa injection for anticoagulant support and thrombosis prevention in Libya.

We Are Here to Support Your Healthcare Needs

Add to cart